Rafael Bejar

Chief Medical Officer, Aptose Biosciences Inc.

Companies

Aptose Biosciences Inc.Chief Medical Officer Jan 3, 2020 to Feb 7, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aptose Biosciences Inc.0 shares²Jun 30, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 30, 2026Returned to company 244 shares at $1.72 of Aptose Biosciences Inc.²
Jan 19, 2023Granted 100,000 shares of Aptose Biosciences Inc.³
Nov 19, 2021Bought 10,000 shares at $2.56 of Aptose Biosciences Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAptose Biosciences Inc., Chief Medical Officer
2
SEC EDGARAptose Biosciences Inc. shares after the filing of Jun 30, 2026
3
SEC EDGARForm 4 filed Jan 23, 2023
4
SEC EDGARForm 4 filed Nov 19, 2021